ResMed Inc. (RMD)
What changed in recent filings
- Risk factors — 3 added · 2 removed · new: We are subject to potential professional se… +210-K Jun 30, 2025 → Jun 30, 2026 · filed 2 months ago
What changed in recent SEC filings — factual, not a buy/sell recommendation.
ResMed Inc. recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Aug 6, 2026Revenue +8.6% YoY · EPS $2.64Released after the close: Aug 6 close → Aug 7 close, the stock moved -5.1% · over the same window, market +0.6% · sector +1.2%
- 26Q1Released Apr 30, 2026Revenue +10.8% YoY · EPS $2.74Released after the close: Apr 30 close → May 1 close, the stock moved -4.1% · over the same window, market +0.3% · sector -1.0%
- 25Q4Released Jan 29, 2026Revenue +11.0% YoY · EPS $2.68Released after the close: Jan 29 close → Jan 30 close, the stock moved +0.3% · over the same window, market -0.3% · sector +0.0%
- 25Q3Released Oct 30, 2025Revenue +9.1% YoY · EPS $2.37Released after the close: Oct 30 close → Oct 31 close, the stock moved -2.1% · over the same window, market +0.3% · sector +0.0%
The next earnings release is estimated around Oct 29, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Company overview
ResMed Inc. is a global medical technology and digital health company focused on sleep health, respiratory care, and out-of-hospital care. ResMed develops and markets cloud-connected medical devices, including positive airway pressure systems, masks, home ventilators, and related accessories used to diagnose and manage sleep apnea and other chronic respiratory disorders. The company also provides software and connected-care platforms that support home healthcare, post-acute care, and care coordination for providers, patients, and caregivers. Its product portfolio serves hospitals, sleep clinics, home medical equipment suppliers, and long-term care organizations across global markets. ResMed Inc. plays an important role in the healthcare market by combining medical devices with software to improve treatment delivery, patient monitoring, and care management in home and clinical settings.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
ResMed Inc. is classified under the Biotech & Health sector. See peers below.
ResMed Inc. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
ResMed Inc. vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding ResMed Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
RMD on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
RMD FAQ
What is ResMed Inc. (RMD)?
ResMed Inc. is a global medical technology and digital health company focused on sleep health, respiratory care, and out-of-hospital care. ResMed develops and markets cloud-connected medical devices, including positive airway pressure systems, masks, home ventilators, and related accessories used to diagnose and manage sleep apnea and other chronic respiratory disorders. The company also provides software and connected-care platforms that support home healthcare, post-acute care, and care coordination for providers, patients, and caregivers. Its product portfolio serves hospitals, sleep clinics, home medical equipment suppliers, and long-term care organizations across global markets. ResMed Inc. plays an important role in the healthcare market by combining medical devices with software to improve treatment delivery, patient monitoring, and care management in home and clinical settings.
What sector is ResMed Inc. in?
ResMed Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are ResMed Inc.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 9.9%, Operating margin 30.7%, Net margin 26.9%, ROE 23.1%, Debt-to-equity 0.06x. Definitions and interpretation are available on Stocklore.
Where can I analyze ResMed Inc. (RMD) stock?
On Stocklore you can see RMD's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.